Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Xinbo Wang, MD
CONTACT
Sizhen Wang, MD
CONTACT
Lead
Sizhen Wang
With
This is a single arm, open-label, single-center study.This study is indicated for advanced relapse-refractory or metastatic pancreatic cancer.The selections of dose levels and the number of subjects are based on clinical trials of similar foreign products. Primary objective is to explore the safety, main consideration is dose-related safety.
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted